Additive manufacturing (AM) has emerged as a cutting-edge technology for fabricating biomimetic scaffolds with controllable architectures and compositional diversity, showing great promise in the fields of bone tissue engineering (BTE) and regenerative medicine. However, due to limitations in printing resolution and single-process capabilities, AM alone struggles to replicate the complex multiscale hierarchical structures inherent in native bone. Traditional fabrication techniques provide valuable complementary strategies to address these limitations. This review systematically summarizes recent advances in the construction of heterogeneous scaffolds from a multiscale design perspective, encompassing macro-, meso-, and microscale approaches. Emphasis is placed on the integration of major AM techniques—such as extrusion-based and light-based printing—with conventional methods including freeze-drying, gas foaming, and electrospinning. Particular attention is given to emerging in situ fabrication strategies, such as in situ foaming and mineralization, which enable spatially resolved and functionally graded architectures. Furthermore, this review explores pathways for constructing multiscale-integrated scaffolds and examines the current challenges and opportunities in clinical translation. Collectively, this work provides a comprehensive framework to guide the development of next-generation bone tissue scaffolds with enhanced biological performance and translational potential.
Injectable calcium phosphate cement (CPC) offers significant benefits for the minimally invasive repair of irregular bone defects. However, the main limitations of CPC, including its deficiency in osteogenic properties and insufficient large porosity, require further investigation and resolution. In this study, alginate–chitosan–alginate (ACA) microcapsules were used to encapsulate and deliver rat bone mesenchymal stem cells (rBMSCs) into CPC paste, while a porous CPC scaffold was established to support cell growth. Our results demonstrated that the ACA cell microcapsules effectively protect the cells and facilitate their transport into the CPC paste, thereby enhancing cell viability post-implantation. Additionally, the ACA + CPC extracts were found to stimulate osteogenic differentiation of rBMSCs. Furthermore, results from a rat cranial parietal bone defect model showed that ACA microcapsules containing exogenous rBMSCs initially improved the in situ osteogenic potential of CPC within bone defects, providing multiple sites for bone growth. Over time, the osteogenic potential of the exogenous cells diminishes, yet the pores created by the microcapsules persist in supporting ongoing bone formation by recruiting endogenous cells to the osteogenic sites. In conclusion, the utilization of ACA loaded stem cell microcapsules satisfactorily facilitate osteogenesis and degradation of CPC, making it a promising scaffold for bone defect transplantation.
Bone morphogenetic protein-2 (BMP-2) is a highly potent osteoinductive factor that has received approval from the U.S. Food and Drug Administration due to its significant osteogenic properties. Nonetheless, its clinical utility is limited by adverse effects linked to supraphysiological dosing and its brief half-life. Consequently, there is a pressing need for a safe and effective delivery system to enable the sustained release of BMP-2. In this study, we have developed bilayer-structured oxidized sodium alginate–carboxymethyl chitosan (OAC) microspheres through the application of electrospraying and the Schiff reaction. The inner layer, composed of oxidized sodium alginate, electrostatically adsorbs BMP-2, while the porous polyelectrolyte membrane on the surface enhances adsorption, thereby effectively regulating the prolonged and controlled release of BMP-2. We assessed the minimal osteogenic induction concentration of BMP-2 on rat bone marrow mesenchymal stem cells (rBMSCs) to optimize the BMP-2 loading concentration within the microspheres. In vitro experiments demonstrated that the bilayer membrane structure of the hydrogel microspheres significantly delayed the release of BMP-2, facilitating a long-term, sustained release. Furthermore, the microspheres facilitated the proliferation, migration, and osteogenic differentiation of rBMSCs. The osteogenic-promoting efficacy of the BMP-2-encapsulated OAC microspheres was further corroborated in vivo through implantation alongside calcium phosphate cement into the dorsal region of nude mice. Collectively, the BMP-2-encapsulated OAC microspheres we developed constitute a promising clinical approach to augment scaffold degradation and osteogenesis for the repair of bone defects.
Removable partial dentures (RPDs) remain a widely used and cost-effective solution for patients with dentition defects. However, their long-term success, particularly in distal extension cases, depends heavily on biomechanical performance. Finite element analysis (FEA) has emerged as a valuable tool for evaluating stress distribution and guiding RPD design. This review synthesizes FEA-based insights into key biomechanical parameters—including abutment selection, clasp geometry, rest position, major connector stiffness, and material properties—with a particular focus on Kennedy Class I and II scenarios, and special attention to implant-supported RPDs (ISRPDs). Recent developments in digital workflows, such as intraoral scanning and CAD/CAM fabrication, have further enabled personalized modeling and rapid optimization. In addition, the integration of artificial intelligence (AI) with FEA shows promises in automating framework generation, predicting stress outcomes, and supporting closed-loop design optimization. While these technologies offer exciting potential, current models still lack integration of patient-specific factors such as mucosal properties, saliva, and gag reflex, contributing to discrepancies between simulations and clinical outcomes. Bridging this gap through improved modeling and data-driven approaches will be key to delivering personalized, biomechanically optimized RPD solutions.
25 November 2025 in Frontiers in Bioengineering and Biotechnology
Background: Composite scaffolds combining polylactic acid (PLA) with β-tricalcium phosphate (β-TCP) offer potential for bone tissue engineering (BTE) by integrating mechanical support with bioactivity. However, the optimal ratio balancing biological performance, structural integrity, and manufacturing feasibility remains unclear. Methods: PLA/β-TCP composites containing 0%, 10%, 20%, and 30% β-TCP were prepared using solvent-free resonant acoustic mixing (RAM), extruded into filaments, and printed by fused deposition modeling (FDM). Scaffolds were evaluated for mechanical properties, printability, and in vitro biocompatibility with rat bone marrow mesenchymal stem cells (rBMSCs). Osteogenic differentiation was assessed by ALP activity, calcium deposition, and expression of osteogenic marker. In vivo bone regeneration was investigated in a rat calvarial defect model. Results: All β-TCP-containing scaffolds enhanced cell adhesion, proliferation, and osteogenesis compared with pure PLA. The 80:20 PLA/β-TCP scaffold showed optimal balance of bioactivity, compressive strength, and printing quality. Excessive β-TCP (>20%) reduced mechanical strength and caused printing defects. In vivo , the 80:20 group showed superior early bone regeneration after 4 weeks, confirmed by micro-CT and histology. Conclusion: The 80:20 PLA/β-TCP composition offers an optimal balance of biological activity, mechanical performance, and manufacturing scalability, supporting its potential as a cost-effective scaffold for clinical BTE applications.